MedPath

Post marketing study to Evaluate safety and efficacy of Suture material (MITSU ABâ?¢ Polyglactin 910) of Meril Endo Surgery Pvt. Ltd in comparision with coated Vicrylâ?¢ Plus Antibacterial (Polyglactin 910) Suture during surgery for closure of surgical incision.

Not Applicable
Completed
Conditions
Health Condition 1: 8- Other Procedures
Registration Number
CTRI/2017/01/007736
Lead Sponsor
Meril EndoSurgery Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
122
Inclusion Criteria

1)Both male and female aged >=18 years old.

2)Subject or a legally authorized representative must provide written Informed Consent prior to any study related procedure.

3)Subjects scheduled for either orthopaedic surgical procedure or gynaecological surgical procedure.

4)Subject agrees not to participate in any other investigational or invasive study for a period of 12 months.

5)Subject agrees to return for scheduled follow-up visits.

Exclusion Criteria

1)Subject has a known allergy with triclosan.

2)Subject with history of HIV.

3)Subject in any case requiring other emergency operations.

4)Subject with on-going sepsis or septicaemia, on-going bacterial infections or antibiotic treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall wound dehiscenceTimepoint: At post-procedure, 14 days and 30 days (±14 days)
Secondary Outcome Measures
NameTimeMethod
Hospital length of stayTimepoint: after the procedure.;Rate of Surgical Site Infection (SSI)Timepoint: At baseline, post procedure/discharge, 14 days (±14 days) and 30 days (±28 days), 6 months (±28 days) and 12 months (±28 days)
© Copyright 2025. All Rights Reserved by MedPath